Shopping Cart
Remove All
Your shopping cart is currently empty
P-gp Inhibitor 13, a P-glycoprotein antagonist, can counteract paclitaxel resistance in A2780/T cells, proving valuable for advanced acute myeloid leukemia research [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | P-gp Inhibitor 13, a P-glycoprotein antagonist, can counteract paclitaxel resistance in A2780/T cells, proving valuable for advanced acute myeloid leukemia research [1]. |
| In vitro | P-gp inhibitor 13 (Compound 27f) significantly chemosensitized A2780/T cells with an IC50 of 0.010 μM [1], increased paclitaxel and rhodamine 123 accumulation by inhibiting P-gp to reverse multidrug resistance (MDR) [1], exhibited minimal cardiotoxicity [1], and showed concentration-dependent MDR reversal at 2.5, 5, 10, and 20 μM in A2780/T cells [1]. |
| Molecular Weight | 546.61 |
| Formula | C32H34O8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.